Silvia Lentini

Differentiation and integrity of cardiac muscle cells are impaired in the absence of βi integrin

Reinhard Fässler, Jürgen Rohwedel, Victor A. Maltsev et al. · Journal of Cell Science · 1996 · 184 citations

Cardiac Muscle, Cardiac Progenitor Cells, Cytoskeleton +23

Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94–8862) in Individuals With Renal Impairment

Roland Heinig, Nina Kimmeskamp‐Kirschbaum, Atef Halabi et al. · Clinical Pharmacology in Drug Development · 2016 · 66 citations

Pharmacokinetics, safety and tolerability of the novel, selective mineralocorticoid receptor antagonist finerenone – results from first‐in‐man and relative bioavailability studies

Silvia Lentini, Roland Heinig, Nina Kimmeskamp‐Kirschbaum et al. · Fundamental and Clinical Pharmacology · 2015 · 59 citations

First‐in‐man–proof of concept study with molidustat: a novel selective oral HIF‐prolyl hydroxylase inhibitor for the treatment of renal anaemia

M. Böttcher, Silvia Lentini, Erich R. Arens et al. · British Journal of Clinical Pharmacology · 2018 · 37 citations · Full text

Absorption, distribution, metabolism and excretion of molidustat in healthy participants

Silvia Lentini, Dorina van der Mey, Armin Kern et al. · Basic & Clinical Pharmacology & Toxicology · 2020 · 12 citations · Full text